Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Steve Soto Trujillo
Observed name:
Steve Soto
Institutions:
University of Southern California,
USC Norris Comprehensive Cancer Center
Observed institutions:
University of Southern California,
USC Norris Comprehensive Cancer Center
ORCID:
0009-0001-5709-8542
Observed ORCID:
0009-0001-5709-8542
OpenAlex ID:
A5132889756
Dihydropyrimidine dehydrogenase modulates immune response to checkpoint inhibition in mismatch repair deficient/microsatellite instability-high colorectal cancer
2026
·
Shivani Soni
, Francesca Battaglin
, et al.
·
Journal for ImmunoTherapy of Cancer
Mitochondrial DNA (mtDNA) expression as used to define metabolic and immune states in colorectal cancer (CRC).
2026
·
Michela Bartolini
, Sharon Wu
, et al.
·
Journal of Clinical Oncology
Data from a real-world study: Association of CDCP1 expression level with survival outcomes in mCRC patients treated with bevacizumab or cetuximab plus chemotherapy.
2026
·
Yitzhar Efraim Goretsky
, Yan Yang
, et al.
·
Journal of Clinical Oncology
PDF
Validation of SNHG11 as a prognostic and predictive biomarker for anti-EGFR benefit in colorectal cancer using real-world data.
2026
·
Michela Bartolini
, Yasmine Baca
, et al.
·
Journal of Clinical Oncology
PDF
Abstract 1011: Correlation of mitophagy related genes expression and clinical outcome in metastatic colorectal cancer patients enrolled in CALGB (Alliance)/SWOG 80405
2026
·
Shivani Soni
, Yan Yang
, et al.
·
Cancer Research
Abstract 6751: Differences in survival outcomes among metastatic colorectal cancer patients across fibroblast growth factor receptor 2 and 3 expression levels
2026
·
Steve Soto Trujillo
, Yan Yang
, et al.
·
Cancer Research
Abstract 2081: Age of host impact on epigenetics in tumors derived from early or late onset Hispanic colorectal cancer patients.
2026
·
Lesly Torres-Gonzalez
, Shivani Soni
, et al.
·
Cancer Research
Abstract 1956: Efficacy of DNA methyltransferase inhibition in combination with immune-checkpoint/PARP-inhibitor in colorectal cancer preclinical model.
2026
·
Pooja Mittal
, Jae Ho Lo
, et al.
·
Cancer Research
Abstract 2105: Transcriptomic insights into MAO B inhibition and bevacizumab synergy in colorectal cancer model.
2026
·
Unnati Hemant Shah
, Shivani Soni
, et al.
·
Cancer Research
Long Non-Coding RNA SNHG11 as a Prognostic and Predictive Biomarker in Metastatic Colorectal Cancer: Evidence From CALGB (Alliance)/SWOG 80405 and Real-World Data
2026
·
Michela Bartolini
, Yan Yang
, et al.
·
SSRN Electronic Journal
PDF
Are You Ethical
2012
·
Steve Soto
Show more works
View as search
Works count:
11
Citation count:
H-index:
I10-index:
Year
Topic
Type